한글목차

세계의 헤파린 원료의약품 시장 규모는 2024년에 12억 3,000만 달러에 달했습니다.

이 시장은 2025-2031년의 예측 기간 중 7.77%의 CAGR로 확대하며, 2031년에는 23억 달러에 달할 것으로 예측됩니다.

북미의 헤파린 원료의약품 시장 규모는 2025년 4억 3,149만 달러에서 2031년에는 6억 7,133만 달러에 달할 것으로 예측되며, 2025-2031년의 예측 기간 중 CAGR은 7.65%에 달할 것으로 보이고 있습니다.

아시아태평양의 헤파린 원료의약품 시장 규모는 2025년 4억 7,850만 달러에서 2031년에는 7억 9,946만 달러에 달할 것으로 예측되며, 2025-2031년의 예측 기간 중 CAGR은 8.93%에 달할 것으로 보이고 있습니다.

유럽의 헤파린 원료의약품 시장 규모는 2025년 5억 3,757만 달러에서 2031년에는 8억 122만 달러에 달할 것으로 예측되며, 2025-2031년의 예측 기간 중 CAGR은 6.88%에 달할 것으로 보이고 있습니다.

헤파린 원료의약품의 주요 세계 제조업체에는 Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioiberica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical 등이 있습니다. 2024년에는 세계의 상위 3 벤더가 판매의 약 38%를 차지하고 있습니다.

헤파린 원료의약품의 세계 시장을 양적·질적 분석 양면으로부터 종합적으로 제시하는 것으로, 독자가 비즈니스/성장 전략을 책정하고, 시장 경쟁 상황을 평가하고, 현재 시장에서 자사의 포지션을 분석하고, 헤파린 원료의약품에 관한 충분한 정보에 기반한 비즈니스 의사결정을 시행할 수 있도록 하는 것을 목적으로 하고 있습니다.

헤파린 원료의약품 시장 규모·추산·예측은 2024년을 기준연도로 하며, 2020-2031년 기간의 이력 데이터와 예측 데이터를 판매 수량(억 단위)과 매출(100만 달러) 측면에서 제공합니다. 세계의 헤파린 원료의약품 시장을 종합적으로 부문화하고 있습니다. 제품 유형별, 용도별, 참여 기업별 지역별 시장 규모도 게재하고 있습니다.

시장을 심층적으로 이해하기 위해 경쟁 구도, 주요 경쟁사의 개요, 각각의 시장 랭크를 게재하고 있습니다. 또한 기술 동향 및 신제품 개발에 대해서도 논하고 있습니다.

헤파린 원료의약품 제조업체, 신규 참여 기업, 이 시장에서의 산업 체인 관련 기업에 대해 시장 전체 및 기업 매출별, 유형별, 용도별, 지역별 서브 부문에서 매출, 판매량, 평균 가격에 관한 정보를 제공합니다.

목차

제1장 헤파린 원료의약품 시장 개요

• 제품 정의
• 헤파린 원료의약품의 유형
• 용도별 헤파린 원료의약품
• 세계의 헤파린 원료의약품 시장 규모 예측
• 전제와 제한

제2장 헤파린 원료의약품 시장 경쟁

제3장 헤파린 원료의약품 시장 시나리오, 지역별

• 세계의 헤파린 원료의약품 시장 규모 : 2020년, 2024년, 2031년, 지역별
• 세계의 헤파린 원료의약품 판매 : 2020-2031년, 지역별
• 세계의 헤파린 원료의약품 매출 : 2020-2031년, 지역별
• 북미
• 유럽
• 아시아태평양
• 라틴아메리카
• 중동 및 아프리카

제4장 유형별 부문

• 세계의 헤파린 원료의약품 판매, 유형별(2020-2031년)
• 세계의 헤파린 원료의약품 매출, 유형별(2020-2031년)
• 세계의 헤파린 원료의약품 가격, 유형별(2020-2031년)

용도별 부문

• 세계의 헤파린 원료의약품 판매, 용도별(2020-2031년)
• 세계의 헤파린 원료의약품 매출, 용도프별(2020-2031년)
• 세계의 헤파린 원료의약품 가격, 용도별(2020-2031년)

제5장 주요 기업의 개요

• Shenzhen Hepalink Pharmaceutical
• Yantai Dongcheng Pharmaceutical
• Pfizer
• Bioiberica
• Changzhou Qianhong Biopharma
• Nanjing King-friend Biochemical Pharmaceutical
• Hebei Changshan Biochemical Pharmaceutical
• Qingdao Jiulong Biopharmaceutical
• Opocrin
• Dongying Tiandong Pharmaceutical
• Aspen Oss
• Yino Pharma
• Nanjing Xinbai Pharmaceutical
• Hubei Enoray Biopharmaceutical
• Cisen Pharmaceutical

제6장 산업 체인과 판매채널 분석

• 헤파린 원료의약품 산업 체인 분석
• 헤파린 원료의약품 원료 공급 분석
• 헤파린 원료의약품 제조 모드와 프로세스 분석
• 헤파린 원료의약품 판매 및 마케팅
• 헤파린 원료의약품 고객 분석

제7장 헤파린 원료의약품 시장 역학

제8장 조사 결과와 결론

제9장 조사 방법과 데이터 소스

영문목차

The global Heparin API market was valued at US$ 1.23 billion in 2024 and is anticipated to reach US$ 2.30 billion by 2031, witnessing a CAGR of 7.77% during the forecast period 2025-2031.

North American market for Heparin API is estimated to increase from $ 431.49 million in 2025 to reach $ 671.33 million by 2031, at a CAGR of 7.65% during the forecast period of 2025 through 2031.

Asia-Pacific market for Heparin API is estimated to increase from $ 478.50 million in 2025 to reach $ 799.46 million by 2031, at a CAGR of 8.93% during the forecast period of 2025 through 2031.

Europe market for Heparin API is estimated to increase from $ 537.57 million in 2025 to reach $ 801.22 million by 2031, at a CAGR of 6.88% during the forecast period of 2025 through 2031.

The major global manufacturers of Heparin API include Shenzhen Hepalink Pharmaceutical, Yantai Dongcheng Pharmaceutical, Pfizer, Bioiberica, Changzhou Qianhong Biopharma, Nanjing King-friend Biochemical Pharmaceutical, Hebei Changshan Biochemical Pharmaceutical, Qingdao Jiulong Biopharmaceutical, Opocrin, Dongying Tiandong Pharmaceutical, etc. In 2024, the world's top three vendors accounted for approximately 38% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Heparin API, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin API.

The Heparin API market size, estimations, and forecasts are provided in terms of sales volume (Billion Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Heparin API market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Heparin API manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

• Shenzhen Hepalink Pharmaceutical
• Yantai Dongcheng Pharmaceutical
• Pfizer
• Bioiberica
• Changzhou Qianhong Biopharma
• Nanjing King-friend Biochemical Pharmaceutical
• Hebei Changshan Biochemical Pharmaceutical
• Qingdao Jiulong Biopharmaceutical
• Opocrin
• Dongying Tiandong Pharmaceutical
• Aspen Oss
• Yino Pharma
• Nanjing Xinbai Pharmaceutical
• Hubei Enoray Biopharmaceutical
• Cisen Pharmaceutical

Segment by Type

• Heparin Sodium API
• Heparin Calcium API

Segment by Application

• UFH
• LMWH

Consumption by Region

• North America
• United States
• Canada
• Asia-Pacific
• China
• Japan
• India
• Rest of APAC
• Europe
• Germany
• France
• U.K.
• Italy
• Spain
• Rest of Europe
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Middle East
• Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Heparin API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Heparin API in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Heparin API Market Overview

• 1.1 Product Definition
• 1.2 Heparin API by Type
  • 1.2.1 Global Heparin API Market Value Comparison by Type (2024 VS 2031)
  • 1.2.2 Heparin Sodium API
  • 1.2.3 Heparin Calcium API
• 1.3 Heparin API by Application
  • 1.3.1 Global Heparin API Market Value by Application (2024 VS 2031)
  • 1.3.2 UFH
  • 1.3.3 LMWH
• 1.4 Global Heparin API Market Size Estimates and Forecasts
  • 1.4.1 Global Heparin API Revenue 2020-2031
  • 1.4.2 Global Heparin API Sales 2020-2031
  • 1.4.3 Global Heparin API Market Average Price (2020-2031)
• 1.5 Assumptions and Limitations

2 Heparin API Market Competition by Manufacturers

• 2.1 Global Heparin API Sales Market Share by Manufacturers (2020-2025)
• 2.2 Global Heparin API Revenue Market Share by Manufacturers (2020-2025)
• 2.3 Global Heparin API Average Price by Manufacturers (2020-2025)
• 2.4 Global Key Players of Heparin API, Industry Ranking, 2022 VS 2023 VS 2024
• 2.5 Global Key Manufacturers of Heparin API, Manufacturing Sites & Headquarters
• 2.6 Global Key Manufacturers of Heparin API, Product Type
• 2.7 Global Key Manufacturers of Heparin API, Founded Date
• 2.8 Global Heparin API Market Competitive Situation and Trends
  • 2.8.1 Global Heparin API Market Concentration Rate
  • 2.8.2 The Global 5 and 10 Largest Heparin API Players Market Share by Revenue
  • 2.8.3 Global Heparin API Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Heparin API Market Scenario by Region

• 3.1 Global Heparin API Market Size by Region: 2020 Versus 2024 Versus 2031
• 3.2 Global Heparin API Sales by Region: 2020-2031
  • 3.2.1 Global Heparin API Sales by Region: 2020-2025
  • 3.2.2 Global Heparin API Sales by Region: 2026-2031
• 3.3 Global Heparin API Revenue by Region: 2020-2031
  • 3.3.1 Global Heparin API Revenue by Region: 2020-2025
  • 3.3.2 Global Heparin API Revenue by Region: 2026-2031
• 3.4 North America Heparin API Market Facts & Figures by Country
  • 3.4.1 North America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
  • 3.4.2 North America Heparin API Sales by Country (2020-2031)
  • 3.4.3 North America Heparin API Revenue by Country (2020-2031)
  • 3.4.4 United States
  • 3.4.5 Canada
• 3.5 Europe Heparin API Market Facts & Figures by Country
  • 3.5.1 Europe Heparin API Market Size by Country: 2020 VS 2024 VS 2031
  • 3.5.2 Europe Heparin API Sales by Country (2020-2031)
  • 3.5.3 Europe Heparin API Revenue by Country (2020-2031)
  • 3.5.4 Germany
  • 3.5.5 France
  • 3.5.6 U.K.
  • 3.5.7 Italy
  • 3.5.8 Spain
• 3.6 Asia Pacific Heparin API Market Facts & Figures by Region
  • 3.6.1 Asia Pacific Heparin API Market Size by Region: 2020 VS 2024 VS 2031
  • 3.6.2 Asia Pacific Heparin API Sales by Region (2020-2031)
  • 3.6.3 Asia Pacific Heparin API Revenue by Region (2020-2031)
  • 3.6.4 China
  • 3.6.5 Japan
  • 3.6.6 India
• 3.7 Latin America Heparin API Market Facts & Figures by Country
  • 3.7.1 Latin America Heparin API Market Size by Country: 2020 VS 2024 VS 2031
  • 3.7.2 Latin America Heparin API Sales by Country (2020-2031)
  • 3.7.3 Latin America Heparin API Revenue by Country (2020-2031)
  • 3.7.4 Mexico
  • 3.7.5 Brazil
• 3.8 Middle East and Africa Heparin API Market Facts & Figures by Country
  • 3.8.1 Middle East and Africa Heparin API Market Size by Country: 2020 VS 2024 VS 2031
  • 3.8.2 Middle East and Africa Heparin API Sales by Country (2020-2031)
  • 3.8.3 Middle East and Africa Heparin API Revenue by Country (2020-2031)
  • 3.8.4 Middle East
  • 3.8.5 Africa

4 Segment by Type

• 4.1 Global Heparin API Sales by Type (2020-2031)
  • 4.1.1 Global Heparin API Sales by Type (2020-2025)
  • 4.1.2 Global Heparin API Sales by Type (2026-2031)
  • 4.1.3 Global Heparin API Sales Market Share by Type (2020-2031)
• 4.2 Global Heparin API Revenue by Type (2020-2031)
  • 4.2.1 Global Heparin API Revenue by Type (2020-2025)
  • 4.2.2 Global Heparin API Revenue by Type (2026-2031)
  • 4.2.3 Global Heparin API Revenue Market Share by Type (2020-2031)
• 4.3 Global Heparin API Price by Type (2020-2031)

Segment by Application

• 4.4 Global Heparin API Sales by Application (2020-2031)
  • 4.4.1 Global Heparin API Sales by Application (2020-2025)
  • 4.4.2 Global Heparin API Sales by Application (2026-2031)
  • 4.4.3 Global Heparin API Sales Market Share by Application (2020-2031)
• 4.5 Global Heparin API Revenue by Application (2020-2031)
  • 4.5.1 Global Heparin API Revenue by Application (2020-2025)
  • 4.5.2 Global Heparin API Revenue by Application (2026-2031)
  • 4.5.3 Global Heparin API Revenue Market Share by Application (2020-2031)
• 4.6 Global Heparin API Price by Application (2020-2031)

5 Key Company Profiled

• 5.1 Shenzhen Hepalink Pharmaceutical
  • 5.1.1 Shenzhen Hepalink Pharmaceutical Corporation Information
  • 5.1.2 Shenzhen Hepalink Pharmaceutical Introduction and Business Overview
  • 5.1.3 Shenzhen Hepalink Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.1.4 Shenzhen Hepalink Pharmaceutical Heparin API Products Offered
• 5.2 Yantai Dongcheng Pharmaceutical
  • 5.2.1 Yantai Dongcheng Pharmaceutical Corporation Information
  • 5.2.2 Yantai Dongcheng Pharmaceutical Introduction and Business Overview
  • 5.2.3 Yantai Dongcheng Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.2.4 Yantai Dongcheng Pharmaceutical Heparin API Products Offered
• 5.3 Pfizer
  • 5.3.1 Pfizer Corporation Information
  • 5.3.2 Pfizer Introduction and Business Overview
  • 5.3.3 Pfizer Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.3.4 Pfizer Heparin API Products Offered
• 5.4 Bioiberica
  • 5.4.1 Bioiberica Corporation Information
  • 5.4.2 Bioiberica Introduction and Business Overview
  • 5.4.3 Bioiberica Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.4.4 Bioiberica Heparin API Products Offered
• 5.5 Changzhou Qianhong Biopharma
  • 5.5.1 Changzhou Qianhong Biopharma Corporation Information
  • 5.5.2 Changzhou Qianhong Biopharma Introduction and Business Overview
  • 5.5.3 Changzhou Qianhong Biopharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.5.4 Changzhou Qianhong Biopharma Heparin API Products Offered
• 5.6 Nanjing King-friend Biochemical Pharmaceutical
  • 5.6.1 Nanjing King-friend Biochemical Pharmaceutical Corporation Information
  • 5.6.2 Nanjing King-friend Biochemical Pharmaceutical Introduction and Business Overview
  • 5.6.3 Nanjing King-friend Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.6.4 Nanjing King-friend Biochemical Pharmaceutical Heparin API Products Offered
• 5.7 Hebei Changshan Biochemical Pharmaceutical
  • 5.7.1 Hebei Changshan Biochemical Pharmaceutical Corporation Information
  • 5.7.2 Hebei Changshan Biochemical Pharmaceutical Introduction and Business Overview
  • 5.7.3 Hebei Changshan Biochemical Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.7.4 Hebei Changshan Biochemical Pharmaceutical Heparin API Products Offered
• 5.8 Qingdao Jiulong Biopharmaceutical
  • 5.8.1 Qingdao Jiulong Biopharmaceutical Corporation Information
  • 5.8.2 Qingdao Jiulong Biopharmaceutical Introduction and Business Overview
  • 5.8.3 Qingdao Jiulong Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.8.4 Qingdao Jiulong Biopharmaceutical Heparin API Products Offered
• 5.9 Opocrin
  • 5.9.1 Opocrin Corporation Information
  • 5.9.2 Opocrin Introduction and Business Overview
  • 5.9.3 Opocrin Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.9.4 Opocrin Heparin API Products Offered
• 5.10 Dongying Tiandong Pharmaceutical
  • 5.10.1 Dongying Tiandong Pharmaceutical Corporation Information
  • 5.10.2 Dongying Tiandong Pharmaceutical Introduction and Business Overview
  • 5.10.3 Dongying Tiandong Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.10.4 Dongying Tiandong Pharmaceutical Heparin API Products Offered
• 5.11 Aspen Oss
  • 5.11.1 Aspen Oss Corporation Information
  • 5.11.2 Aspen Oss Introduction and Business Overview
  • 5.11.3 Aspen Oss Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.11.4 Aspen Oss Heparin API Products Offered
• 5.12 Yino Pharma
  • 5.12.1 Yino Pharma Corporation Information
  • 5.12.2 Yino Pharma Introduction and Business Overview
  • 5.12.3 Yino Pharma Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.12.4 Yino Pharma Heparin API Products Offered
• 5.13 Nanjing Xinbai Pharmaceutical
  • 5.13.1 Nanjing Xinbai Pharmaceutical Corporation Information
  • 5.13.2 Nanjing Xinbai Pharmaceutical Introduction and Business Overview
  • 5.13.3 Nanjing Xinbai Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.13.4 Nanjing Xinbai Pharmaceutical Heparin API Products Offered
• 5.14 Hubei Enoray Biopharmaceutical
  • 5.14.1 Hubei Enoray Biopharmaceutical Corporation Information
  • 5.14.2 Hubei Enoray Biopharmaceutical Introduction and Business Overview
  • 5.14.3 Hubei Enoray Biopharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.14.4 Hubei Enoray Biopharmaceutical Heparin API Products Offered
• 5.15 Cisen Pharmaceutical
  • 5.15.1 Cisen Pharmaceutical Corporation Information
  • 5.15.2 Cisen Pharmaceutical Introduction and Business Overview
  • 5.15.3 Cisen Pharmaceutical Heparin API Sales, Revenue and Gross Margin (2020-2025)
  • 5.15.4 Cisen Pharmaceutical Heparin API Products Offered

6 Industry Chain and Sales Channels Analysis

• 6.1 Heparin API Industry Chain Analysis
• 6.2 Heparin API Raw Material Supply Analysis
  • 6.2.1 Key Raw Materials
  • 6.2.2 Raw Materials Key Suppliers
• 6.3 Heparin API Production Mode & Process Analysis
• 6.4 Heparin API Sales and Marketing
  • 6.4.1 Heparin API Sales Channels
  • 6.4.2 Heparin API Distributors
• 6.5 Heparin API Customer Analysis

7 Heparin API Market Dynamics

• 7.1 Heparin API Industry Trends
• 7.2 Heparin API Market Drivers
• 7.3 Heparin API Market Challenges
• 7.4 Heparin API Market Restraints

8 Research Findings and Conclusion

9 Methodology and Data Source

• 9.1 Methodology/Research Approach
  • 9.1.1 Research Programs/Design
  • 9.1.2 Market Size Estimation
  • 9.1.3 Market Breakdown and Data Triangulation
• 9.2 Data Source
  • 9.2.1 Secondary Sources
  • 9.2.2 Primary Sources
• 9.3 Author Details
• 9.4 Disclaimer 107